The next four weeks is going to be interesting. We still are waiting for NASH press release and this latest cancer news, I wouldnt be surprised with anything announced on the partners end. The lawyers here (bl & craig) suspected the current deal it is taking time to finalize. Given so many different opportunities NASH, cancer, etc), I could see how cutting out just HIV only (in US) and getting it right the first time might take some effort, especially since leonlimab is so unusual from a standard drug license with so many different potential applications in different areas, some yet unexplored, some potential bigger than the HIV deal. Sounds like a very unusual situation these lawyers are working on.